[Análise eletroforética (SDS-PAGE) de proteínas urinárias de cães de acordo com o estágio da doença renal crônica]

abmvz Arquivo Brasileiro de Medicina Veterinária e Zootecnia Arq. Bras. Med. Vet. Zootec. 0102-0935 1678-4162 Universidade Federal de Minas Gerais, Escola de Veterinária RESUMO A proteinúria glomerular é caracterizada pela perda de proteínas de alto peso molecular (PAPM), enquanto a proteinúria tubulointersticial se caracteriza pela perda de proteínas de baixo peso molecular (PBPM). O objetivo do trabalho foi determinar o peso molecular das proteínas urinárias (PMPU) de cães com DRC naturalmente adquirida e a proporção de PAPM e PBPM de acordo com o estágio da DRC. Foram utilizados 28 cães com DRC, divididos em quatro grupos, de acordo com o nível sérico de creatinina (cr) (grupo 1: cr<1,4, n=8; grupo 2: 1,4<cr< 2,0, n=6; grupo 3: 2,1<cr<5, n=9; grupo 4: cr>5,0, n=5). O grupo controle era composto por cinco cães saudáveis. O PMPU foi determinado por SDS-PAGE. A relação proteína:creatinina urinária (RPCU) foi utilizada como um método quantitativo de proteinúria. A eletroforese revelou uma perda proporcionalmente maior de PAPM, quando comparada às PBPM, em todos os grupos de DRC, bem como uma perda crescente de PBPM no grupo 4 (P<0,05). Esses resultados sugerem uma predominância de lesão glomerular em todos os estágios de DRC nesses cães e uma progressão crescente na lesão túbulo-intersticial no estágio terminal da doença. Os resultados deste estudo reafirmam a recomendação de que a eletroforese de proteínas urinárias é uma técnica qualitativa efetiva de avaliação da proteinúria, bem como um método que permite avaliar a extensão e a localização da lesão renal. INTRODUCTION Chronic kidney disease (CKD) has a high morbidity in elderly canine populations and occurs when there is a structural and/or functional impairment in one or both kidneys that persists for at least three months (Lee, 2004; Roudebush et al., 2009; Polzin, 2011b; Bartges, 2012). Proteinuria is correlated with the progression of CKD and is defined as the presence of abnormal amounts of protein in the urine and can originate from prerenal, renal or postrenal causes (Lees et al., 2005; Grauer, 2007; Polzin, 2007). The origin of pathological renal proteinuria can be glomerular or tubulointerstitial (Lees et al., 2005; Grauer, 2007; Polzin, 2007; Chew et al., 2011; Syme and Elliot, 2011). Proteinuria is of prognostic importance for CKD in dogs and cats (Grauer, 2005a, 2005b; Jacob et al., 2005; Kriz and Lehir, 2005; Grauer, 2007; Polzin, 2007; Kuwahara et al., 2008; Chew et al., 2011; Elliot and Watson, 2010; Syme and Elliot, 2011). There is increasing evidence that proteinuria causes tubulointerstitial and perhaps glomerular injuries, resulting in a progressive loss of nephrons (Burton and Harris, 1996; Finco et al., 1999; Grauer, 2005a, 2005b, 2007; Jepson et al., 2009; Littman, 2011). Studies have shown that dogs with CKD and persistent proteinuria are at greater risk of experiencing a fatal uremic crisis than nonproteinuric patients (Jacob et al., 2005). Under physiological conditions, insignificant amounts of proteins with molecular weight greater than or equal to 70kDa pass through the glomerular barrier (Lulich and Osborne, 1990; Russo et al., 2002; D´Amico and Bazzi, 2003; Syme and Elliot, 2011). Only a small portion of intermediate-molecular-weight proteins (especially albumin) and almost no high-molecular-weight proteins (HMWPs) reach the tubule (Russo et al., 2002; D´Amico and Bazzi, 2003). Conversely, the majority of low molecular-weight proteins (LMWPs) reach the proximal tubule. All proteins that reach the tubule are eliminated in negligible amounts in the urine due to tubular reabsorption (D´Amico and Bazzi, 2003; Lees et al., 2005). Therefore, the presence of HMWP and/or excess albumin characterizes glomerular proteinuria, whereas tubular proteinuria is defined by the presence of LMWP (D´Amico and Bazzi, 2003; Zaragoza et al., 2003; Hart, 2005). Mild increases in albumin can result from either increased glomerular filtration or reduced tubular reabsorption (Hart, 2005). Loss of glomerular permselectivity is associated with a proportionally greater increase in the passage of albumin and HMWP than that of LMWP (D´Amico and Bazzi, 2003). A moderate increase in glomerular permeability occurs in the initial stages of some glomerular diseases (minimal-change nephropathy, primary focal segmental glomerulosclerosis, diabetic nephropathy, membranous nephropathy). In these cases, there is a greater increase in transglomerular passage of intermediate-molecular-weight proteins, including albumin, than that of HMWP (D´Amico and Bazzi, 2003; Hart, 2005), and since they are only partially reabsorbed by cells of the proximal tubule, they are eventually eliminated in the urine (Rego et al., 2001 Smets et al., 2010). A qualitative analysis of urinary proteins, based on molecular weight, can be used to determine the origin of proteinuria and the location of renal injuries (Gorg et al., 1985; Weber, 1988; Lapin et al., 1989; Schultze and Jensen, 1989). Several studies have demonstrated the effectiveness of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for the qualitative analysis of proteins (Weber, 1988; Schultze and Jensen, 1989; Waller et al., 1989; Kawakami et al., 1990). SDS-PAGE separates proteins based on their molecular weight (Waller et al., 1989), and its results correlate well with histologic renal lesions, demonstrating the potential value of this technique for detecting and locating such lesions (Schultze and Jensen, 1989). The use of SDS-PAGE can reduce the need for kidney biopsy in the diagnosis of kidney disease in humans (Lau and Woo, 2002). Another study showed that tubular proteinuria is an indicator of the severity of tubulointerstitial injury and that it is associated with the intensity of azotemia in dogs with progressive glomerular disease (Lazaretti et al., 2006). The aim of this study was to assess the molecular weight of urinary proteins in dogs with naturally acquired CKD using SDS-PAGE, determine the proportion of proteins with high (> 60kDa) and low (< 60kDa) molecular weights at different stages of kidney disease and characterize proteinuria according to the stage of CKD. MATERIALS AND METHODS This prospective observational study was conducted in accordance with all guidelines of Universidade Federal Fluminense and with approval from the institutional animal care committee under the protocol with registered permit number 274. All clients were informed about the study and gave their consent. Patient study groups included healthy dogs and dogs with naturally acquired CKD. The control group consisted of five clinically healthy dogs (4 males and 1 female) over seven years of age, with no known preexisting disease, and whose blood tests (CBC, BUN, creatinine, alanine aminotransferase, alkaline phosphatase, cholesterol, triglycerides, proteins and fractions, glucose, phosphorous, calcium, sodium, potassium), urinalyses, blood pressure and abdominal ultrasound were all normal. The inclusion criteria for the CKD groups were based on serum creatinine in accordance with the previous guidelines developed by the International Renal Interest Society (IRIS) (Elliot and Watson, 2010): CKD stage 1, nonazotemic dogs, but with other renal abnormalities; CKD stage 2, serum creatinine 1.4 - 2.0mg/dL; CKD stage 3, serum creatinine levels between 2.1 and 5,0mg/dL; and CKD stage 4, serum creatinine level greater than 5.0mg/dL. All animals had CKD that was diagnosed at least 3 months previously. Animals were divided into patient groups based on serum creatinine levels. Eight non azotemic (creatinine < 1.4mg/dL) patients (7 males and 1 female) were included in group 1, all of which showed at least one permanent change to kidney structure upon ultrasound examination (calcifications, nephrolithiasis, diminished corticomedullary differentiation, reduced size or irregular shape). Six dogs (3 males and 3 females) with serum creatinine between 1.4 and 2.0mg/dL were included in group 2, whereas group 3 contained nine dogs (6 males and 3 females) with serum creatinine levels between 2.1 and 5.0mg/dL; group 4 consisted of five dogs (3 males and 2 females) whose serum creatinine levels were greater than 5.0mg/dL. These twenty-eight dogs included in the CKD groups had stable renal function and had at least two serum creatinine tests performed one to two weeks apart when they were well-hydrated, and they were selected regardless of breed, sex and age. The exclusion criteria used were patients with suspected acute kidney injury, obstructive diseases of the lower and upper urinary tracts, obesity, diagnoses of any endocrine disorder, and/or use of chronic medication for other diseases (e.g., epilepsy, neoplasia, chronic inflammatory diseases, hemoparasites). Blood and urine samples were obtained from all animals. Abdominal ultrasound was also performed, and systolic blood pressure was measured by the Doppler method in all dogs. An aliquot of 15(L of concentrated urine was diluted for SDS-PAGE. Urine samples were obtained by cystocentesis and subjected to complete urinalysis, determination of urine protein:creatinine ratio and centrifugation (2000 rpm/ 10 minutes). Samples were frozen and stored at -20oC until gel electrophoresis was performed. Measurements of total protein and creatinine were obtained from the supernatant of centrifuged urine samples with inactive sediment (without red blood cells, white blood cells, epithelial cells, bacteria, urine crystals, amorphous debris), and UPC was determined by the simple division of values obtained, as described by White et al. (1984). Urinary creatinine was determined using the Creatinine K test kit (Creatinine K test kit, Ref.96 - Labtest® Diagnóstica SA, Brazil). Urinary proteins were assessed using a pyrogallol red protein dye-binding assay (Sensiprotkit, Ref. 36-200 - Labtest® Diagnóstica SA, Brazil) as described by Watanabe et al. (1986). Each animal’s UPC was determined at least twice with a minimum 2-week interval to establish persistent proteinuria (Polzin, 2011). The proteinuria classification was based on substaging guidelines developed by IRIS (Lees et al., 2005; Elliot and Watson, 2010). Electrophoretic assays were performed using homogeneous SDS-PAGE in a mini-vertical electrophoresis system (Model no. LCV-10X10NC, LoccusBiotecnologia®, São Paulo, Brazil) containing a set of vertical plates (stacking and separating gels), as described by Laemmli (1970), following concentration of urinary proteins with a Minicon® B15 Static Concentrator (Minicon® B15 Static Concentrator, Ref. 9031 - Merck Millipore, Billerica, MA). After urine concentration a correction factor was calculated for each sample according to the difference between the initial and final volume (urine concentration factor). Pierce™ Blue Prestained Protein Molecular Weight Marker Mix (No. 26681 - Thermo Scientific®, Asheville, USA) ranging from 18.3 to 215kDa, was used as a standard. The stacking gel consisted of 4% polyacrylamide (99.32% acrylamide and 0.68% N,N'-Methylenebisacrylamide) in 0.25M Tris-HCl buffer - pH 6.8, containing 0.1% SDS, 0.1% APS (ammonium persulfate solution) and 0.02% TEMED® (N,N,N',N'-Tetramethylethylenediamine - Sigma-Aldrich), whereas the separating gel was composed of 15% polyacrylamide in 3 M Tris-HCl buffer - pH 8.8, containing 0.033% SDS, 0.084% APS and 0.0084% TEMED®. Gels were 0.75mm thick, 11cm wide and approximately 10cm high. Each gel contained 12 wells. In preparation for electrophoresis, 15(L of concentrated urine samples were subjected to a 3:4 dilution in sample buffer (0.25M Tris-HCl - pH 6.8; 23% glycerol; 2.7% SDS; 6.7% β-mercaptoethanol; and 6.7% Bromophenol Blue). The mixture was boiled for 5 minutes before being loaded onto the gel. Each well received the total volume of sample solution (20(L) obtained, for a total of 10 urine samples per gel, leaving one well for the molecular weight standard and one for gel differentiation. Electrophoretic runs were performed using the preset voltages of 140 and 190 volts for the stacking and separating gels, respectively, with a total running time of approximately 3 hours. The gels were fixed in a 40% methanol and 3% glycerol solution and were subsequently stained using 0.125% Coomassie Brilliant Blue R-250 (in 50% methanol and 10% acetic acid) for 30 minutes. Excess dye was removed by soaking the gels in a destaining solution (25% methanol and 10% acetic acid) until the background of the gel was completely destained. Gels were scanned, and a digital image was obtained using a printer/scanner (HP Laser Jet M1120 MFP® - Hewlett-Packard Company, Houston, USA). Visual assessment and comparison to molecular weight standards and migration distance on the gel were used to estimate the molecular weight of each protein band. Each image was also subjected to densitometric analysis using Scion Image Software (Release Beta 3b®, Scion Corporation, USA). Densitometric analysis was used to determine the proportions of HMWPs and LMWPs, as described by Osborne et al. (1995) and Zaragoza et al. (2003). The amount of protein was comparatively estimated for each electrophoretic run using the densitometric analysis provided by the software. To determine the amount of protein in a comparative unit (CU) based on molecular weight, the percentage of each protein band was multiplied by the amount of proteins estimated by the software, and the result was subsequently divided by the urine’s concentration factor and volume of concentrated urine used for the run, thereby resulting in a value with a comparative unit of protein per μL of urine (CU/μL). The amount of protein in CU/μL was calculated for total proteins, HMWPs and LMWPs. SAS System® software was used to perform statistical analyses. The effect of the CKD group was assessed through analysis of variance (ANOVA), and Duncan's test was used for the comparison of group means at a 5% significance level, after having been previously tested. RESULTS The digital image obtained of one gel is shown in Figure 1 as an illustration of the electrophoretic product. Tables 1, 2 and 3 show the mean, standard deviation, minimum and maximum values for the proportion of HMWPs and LMWPs, amount of proteins, HMWPs and LMWPs in CU/μL, urine specific gravity (USG) and UPC. Figure 1 Digital image of gel 4 with SDS-PAGE of urinary proteins of 8 dogs with CKD and the molecular weight marker. Table 1 Mean, standard deviation, minimum and maximum values of the proportions of high-molecular-weight protein (HMWP) and low-molecular-weight protein (LMWP) shown as percentages from urinary protein electrophoresis of dogs in the control group and groups 1, 2, 3 and 4 of CKD. Niterói, 2018 Group Variable HMWP > 60kDa (%) Lmwp < 60kDa (%) Control (n=5) M + SD (Vmin-Vmax) 54.2A+ 14.5 (41.2 -71.0) 45.8A+ 14.5 (28.9 - 58.7) 1 (n=8) M + SD (Vmin-Vmax) 57.1A+ 14.2 (29.5 - 72.3) 42.9A+ 14.2 (27.7 - 70.5) 2 (n=6) M + SD (Vmin-Vmax) 59.8A+ 23.6 (18.8 - 83.4) 40.2A+ 23.6 (16.6 - 81.2) 3 (n=9) M + SD (Vmin-Vmax) 65.7A+ 21.2 (33.1 - 89.1) 34.2A+ 21.1 (10.9 - 66.9) 4 (n=5) M + SD (Vmin-Vmax) 56.9A+ 24.6 (17.5 - 84.4) 43.0A+ 24.6 (15.6 - 82.5) n - number of animals; M - Mean; SD - Standard deviation; Vmin - Minimum value; Vmax - Maximum value; A- means in the same column followed by the same letter did not differ significantly according to Duncan’s test at a 5% significance level. Table 2 Mean, standard deviation, minimum and maximum values of results obtained for urinary total protein, high-molecular-weight protein (HMWP) and low-molecular-weight protein (LMWP)in the comparative unit (CU/μL) of dogs in the control group and groups 1,2,3 and 4 OF CKD. Niterói, 2018 Group Variable Total Protein (CU/ μL) HMWP (CU/ μL) LMWP (CU/ μL) Control (n=5) M + SD (Vmin-Vmax) 0.98A+ 0.32 (0.71 -1.50) 0.55A+ 0.30 (0.31- 1.06) 0.43B+ 0.13 (0.26 - 0.62) 1 (n=8) M + SD (Vmin-Vmax) 1.83A+ 1.22 (0.20 - 3.93) 1.17A+ 0.90 (0.06 - 2.79) 0.67B+ 0.35 (0.14 - 1.14) 2 (n=6) M + SD (Vmin-Vmax) 4.89A+ 4.56 (0.78 - 12.24) 3.62A+ 4.01 (0.17 - 10.06) 1.27B+ 0.67 (0.30 - 2.18) 3 (n=9) M + SD (Vmin-Vmax) 11.46A+ 21.54 (0.56 - 68.0) 9.60A+ 19.00 (0.18 - 59.42) 1.86A B+ 2.59 (0.37 - 8.58) 4 (n=5) M + SD (Vmin-Vmax) 9.05A+ 4.31 (3.83 - 15.02) 5.60A+ 3.47 (0.67 - 10.13) 3.44A+ 1.59 (1.21 - 5.06) n - number of animals; CU - Comparative unit; HMWP - high-molecular-weight protein (MW > 60kDa); LMWP - low-molecular-weight protein (MW < 60kDa); M - Mean; SD - Standard deviation; Vmin - Minimum value; Vmax - Maximum value; A/B- means in the same column followed by different letters differed significantly according to Duncan’s test at a 5% significance level. Table 3 Mean, standard deviation, minimum and maximum values of results obtained for urine specific gravity and urine protein:creatinine ratio (UPC) of dogs in the control group and groups 1, 2, 3 and 4 of CKD. Niterói, 2018 Group Variable Urine specific gravity UPC Control (n=5) M + SD (Vmin-Vmax) 1.043A+ 0.015 (1.024 - 1.060) 0.18B+ 0.10 (0.09 - 0.33) 1 (n=8) M + SD (Vmin-Vmax) 1.022B+ 0.012 (1.012 - 1.048) 0.39B+ 0.29 (0.13 - 0.97) 2 (n=6) M + SD (Vmin-Vmax) 1.020B+ 0.004 (1.012 - 1.024) 1.07B+ 0.87 (0.09 - 2.25) 3 (n=9) M + SD (Vmin-Vmax) 1.012 B+ 0.002 (1.010 - 1.016) 3.25A+ 2.65 (0.62 - 9.35) 4 (n=5) M + SD (Vmin-Vmax) 1.013B+ 0.001 (1.012 - 1.014) 3.56A+ 3.49 (1.60 - 9.80) n - number of animals; UPC - Urine protein:creatinine ratio; M - Mean; SD - Standard deviation; Vmin - Minimum value; Vmax - Maximum value; A/B- means in the same column followed by different letters differed significantly according to Duncan’s test at a 5% significance level. Six dogs in group 1 had USG below 1.025. Three animals had borderline proteinuria (UPC between 0.2 and 0.5), and two were proteinuric (UPC > 0.5). Patients with CKD showed greater urinary protein loss than patients in the control group. Values for protein, HMWP and LMWP in CU/μL and UPC were higher than those observed in the control group, despite the lower USG. Loss of HMWP (> 60kDa %) was higher than that observed in the control group. Urine specific gravity was below 1.025 in all animals in group 2, and one patient (16.67%) was within the isosthenuric range. One dog had borderline proteinuria and four were proteinuric. Higher values of protein, HMWP and LMWP in CU/μL, as well as UPC, revealed increased protein loss in group 2 when compared to that of group 1 and the control group. A predominant loss of HMWP was also noted.All dogs in group 3 had low USG, and five (55.56%) of them were within the isosthenuric range. All animals were proteinuric. Loss of urinary protein was greatest in group 3 when compared to that in all the other groups in terms of protein, HMWP in CU/μL and UPC. HMWPs were predominantly lost. All animals in group 4 had a low USG (below 1.020), and three (60.0%) of them were within the isosthenuric range. Based on UPC, all animals had proteinuria. The higher values of protein, HMWP and LMWP in CU/μL observed in this group show that protein loss was greater than that in groups 1 and 2 and the control group. Total protein loss (protein, HMW in CU/μL and UPC) was lower than that in group 3; however, the loss of LMWP was greater. A predominance of HMWP was noted. Based on analysis of variance, a significant difference was noted between the CKD groups regarding UPC and the amount of LMWP in CU/μL (p<0.05), groups 3 and 4 had higher values for these parameters. No significant differences were noted among the CKD groups with respect to USG; however, a significant difference was observed when comparing all CKD groups to the controls. Low USG was found in six animals (75%) in group 1 and all animals in groups 2, 3 and 4. When assessing proteinuria through UPC, a significant difference was noted between groups 2 and 3, with more severe proteinuria found in the latter. Equivalent proteinuria was observed in groups 1 and 2 and the control group, and in groups 3 and 4. Proteinuria was more severe in groups with advanced CKD and occurred in all animals in groups 3 and 4. Moreover, the proportion of animals with true proteinuria in each group also increased up to groups 3 and 4 (1 = 25%; 2 = 66.67%; 3 = 100%; 4 = 100%). Considering all animals with CKD, 70.4% showed true proteinuria (UPC > 0.5), 14.8% had UPC values between 0.2 and 0.5 (borderline proteinuria), and only 14.8% had no proteinuria. The loss of LMWP in CU/(L was significantly higher in group 4 than in groups 1 and 2 and the control group. Group 3 was statistically similar to all groups. Although no significant differences were found for the remaining variables, certain trends could be noted (Figure 2). When considering the proportions of proteins, group 3 showed the greatest trend toward losing HMWP. The loss of HMWP was predominant in all groups (Figure 3). Figure 2 Urinary protein loss expressed in comparative unit (CU/µL) in dogs in the control group and groups1, 2, 3 and 4 of CKD regarding the amount of proteins in CU/μL, it was noted that total protein and HMWP had similar trends, with greater losses observed in group 3, followed by groups 4, 2, 1 and the control group, in descending order.HMWP - high-molecular-weight protein, LMWP - low-molecular-weight protein. Figure 3 Urinary protein loss expressed as average percentage in dogs in the control group and groups 1, 2, 3 and 4 of CKD. HMWP - high-molecular-weight protein, LMWP - low-molecular-weight protein. DISCUSSION The identification of the origin of urinary proteins can be useful in investigating the cause of CKD in early stages and factors involved in the progression of the disease, while also reflecting the location and severity of the injury (Hart, 2005; Raila, et al., 2007; Smets et al., 2010). This study demonstrates that proteinuria is a consistent finding in dogs with CKD and suggests that glomerular injury is predominant in all stages of CKD and that tubular injuries occur thereafter, becoming more intense in later stages of the disease (Gorg et al., 1985; Weber, 1988; Lapin et al., 1989; Schultze and Jensen, 1989). The severity of CKD in dogs appears to be mediated by both glomerular and tubulointerstitial injuries (Raila, et al., 2007; Yabuki et al., 2010). Both types of injuries are important for the pathophysiology and progression of kidney disease in humans, and increasing evidence points to glomerular proteinuria causing tubular injury (Satirapoj et al., 2012), although the opposite has also been shown to occur (Eardley and Cockwell, 2005). The results obtained from the control group confirm that, under normal conditions, only a small amount of protein is eliminated in the urine. No significant difference or changes above the normal range were observed regarding UPC. Analysis of proteinuria by electrophoresis in the control group and group 1 showed a greater amount of HMWP and LMWP in the urine of animals included in the latter group. The increase in HMWP was proportionally greater than that observed for LMWP. These results suggest that the identification of the type of proteinuria plays an important role in the diagnosis of early CKD, when USG and UPC may still be within normal ranges (Uechi et al., 1994). An established normal range for electrophorectic variables, however, is still lacking. The presence of HMWP and LMWP in the urine of healthy control dogs may be explained by physiological protein constituents in the urine (Weber, 1988) but these normal ranges have yet to be determined. When analyzing the mean UPC, it was possible to note a trend toward increased severity of proteinuria up to group 3 (Figure 4). The trend observed for UPC was statistically confirmed in groups 2 and 3. Figure 4 Urinary protein loss expressed in UPC (urine protein:creatinine ratio) in dogs of the control group and groups 1, 2, 3 and 4 of CKD. The major limitation of this study was the small population size which may allow some data obtained to not be representative of the general population. Another limitation was the lack of histopathological investigations, which could confirm our conclusions. When analyzing the concentrations of total proteins and HMWPs in CU/μL, it was possible to note a trend toward greater protein loss up to group 3, followed by a slight reduction in loss in group 4. These data suggest an increase in proteinuria up to group 3 and a reduction in group 4 (Figure 5). The increasing trend can be justified by the fact that proteinuria is probably one of the perpetuating factors of CKD (Grauer, 2005a, 2007; Littman, 2011). The slight reduction in group 4 may be explained by the reduced renal mass that decreases total proteinuria, although proteinuria per nephron remains high (Lees et al., 2005; Polzin, 2007; Elliot and Watson, 2010). The glomerular or tubular origin of injury may be suggested by determining the proportions of high- and low-molecular-weight proteins (Gorg et al., 1985; Weber, 1988; Lapin et al., 1989; Schultze and Jensen, 1989). A greater amount of LMWP loss occurred in stage 4 CKD, suggesting a worse degree of tubular injury. The present study showed an increasing proportion of HMWPs, with maximum values observed in group 3 (65.74%), whereas the maximum concentration of LMWPs was found in group 4 (3.44 UC/μL). These data support the concept presented in other studies that have suggested that glomerular injury is predominant in all stages of CKD with tubular injuries occurring as a consequence of that injury. The literature supports this observation by stating that glomerular damage initially results in large amounts of albumin in the urine and, as it progresses, there is an increase in the amount of HMWP, whereas tubular injury is characterized by increased amounts of LMWP (Schultze and Jensen, 1989; Lulich and Osborne, 1990; Rego et al., 2001; D´Amico and Bazzi, 2003; Zaragoza et al., 2003; Hart, 2005). Tubular injury can occur as a consequence of glomerular injury because the increased amount of proteins in the tubules overwhelms the tubular reabsorptive capacity and can also be accompanied by lysosomal rupture and apoptosis. Moreover, the mere presence of proteins triggers the release of inflammatory factors that further aggravate tubular damage (Russo et al., 2002; Grauer, 2005a; Smets et al., 2010; Satirapoj et al., 2012). Figure 5 Total urinary protein loss expressed in comparative units (CU/µL) in dogs of the control group and groups 1, 2, 3 and 4 of CKD. CONCLUSIONS The present study allowed us to conclude that proteinuria based on the UPC ratio is more intense up to stage 3 of CKD, when it reaches a maximum. HMWP elimination increases until stage 3 of CKD, and maximum loss of LMWP occurs in the most advanced stage of CKD. The loss of HMWP is predominant throughout all stages of CKD in dogs, and the loss of LMWP is more severe at the most advanced stage of the disease, suggesting predominant glomerular injury in all stages of CKD. In addition to the determination of proteinuria through UPC, the qualitative assessment of urinary proteins through electrophoresis can aid in the diagnosis of kidney disease, since it enables an initial assessment of the severity and probable location of renal injury. ACKNOWLEDGEMENTS We thank Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ) who funded the study and all the dogs and their owners who allowed our study to be performed. et al., REFERENCES BARTGES, J.W. Chronic kidney disease in dogs and cats. Vet. Clin. Small Anim., v.42, p.669-692, 2012. BARTGES J.W Chronic kidney disease in dogs and cats Vet. Clin. Small Anim. 42 669 692 2012 BURTON, C.; HARRIS, K.P.G. The role of proteinuria in the progression of chronic renal failure. Am. J. Kidney Dis., v.27, p.765-775, 1996. BURTON C. HARRIS K.P.G The role of proteinuria in the progression of chronic renal failure Am. J. Kidney Dis. 27 765 775 1996 CHEW, D.J.; DiBARTOLA, S.P.; SCHENCK, P. Chronic renal failure. In: ______. Canine and feline nephrology and urology, 2.ed Missouri: Elsevier-Saunders; 2011.p. 145-196. CHEW D.J. DiBARTOLA S.P. SCHENCK P Chronic renal failure CHEW D.J. DiBARTOLA S.P. SCHENCK P Canine and feline nephrology and urology 2 Missouri Elsevier-Saunders 2011 145 196 D´AMICO, G.; BAZZI, C. Pathophysiology of proteinuria. Kidney Int., v.63, p.809-825, 2003. D´AMICO G. BAZZI C Pathophysiology of proteinuria Kidney Int. 63 809 825 2003 EARDLEY, K.S.; COCKWELL, P. Macrophages and progressive tubulointerstitial disease. Kidney Int., v.68, p.437-455, 2005. EARDLEY K.S. COCKWELL P Macrophages and progressive tubulointerstitial disease Kidney Int. 68 437 455 2005 ELLIOT, J.; WATSON, A.D.J. Overview of the IRIS staging system for CKD. London/Sydney, 2010. Available at: <http://.iris-kidney.com>. Accessed 10 May 2011. ELLIOT J. WATSON A.D.J Overview of the IRIS staging system for CKD London/Sydney 2010 http://.iris-kidney.com FINCO, D.R.; BROWN, S.A.; BROWN, C.A. et al. Progression of chronic renal disease in the dog. J. Vet. Int. Med., v.13, p.516-528, 1999. FINCO D.R. BROWN S.A. BROWN C.A. Progression of chronic renal disease in the dog J. Vet. Int. Med. 13 516 528 1999 GORG, A.; POSTEL, W.; WESER, J. et al. Horizontal SDS eletrophoresis in ultrathin pore-gradient gels for the analysis of urinary proteins. Sci. Tools, v.32, p.5-9, 1985. GORG A. POSTEL W. WESER J. Horizontal SDS eletrophoresis in ultrathin pore-gradient gels for the analysis of urinary proteins Sci. Tools 32 5 9 1985 GRAUER, G.F. Canine glomerulonephritis: new thoughts on proteinuria and treatment. J. Small Anim. Pract., v.46, p.469-478, 2005a. GRAUER G.F Canine glomerulonephritis: new thoughts on proteinuria and treatment J. Small Anim. Pract. 46 469 478 2005 GRAUER, G.F. Early detection of renal damage and disease in dogs and cats. Vet. Clin. Small Anim. Pract., v.35, p.581-596, 2005b. GRAUER G.F Early detection of renal damage and disease in dogs and cats Vet. Clin. Small Anim. Pract. 35 581 596 2005 GRAUER, G.F. Measurement, interpretation, and implications of proteinuria and albuminuria. Vet. Clin. Small Anim. Pract., v.37, p.283-295, 2007. GRAUER G.F Measurement, interpretation, and implications of proteinuria and albuminuria Vet. Clin. Small Anim. Pract. 37 283 295 2007 HART, S.G.E. Assessment of renal injury in vivo. J. Pharma. Toxic. Methods, v.52, p.30-45, 2005. HART S.G.E Assessment of renal injury in vivo J. Pharma. Toxic. Methods 52 30 45 2005 International Renal Interest Society - IRIS. IRIS Staging of CKD [Online]. 2010. Available from: http://www.iris-kidney.com Accessed 10 May 2013. International Renal Interest Society - IRIS IRIS Staging of CKD [Online] 2010 http://www.iris JACOB, F.; POLZIN, D.J.; OSBORNE, C.A. et al. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure. J. Am. Vet. Med. Assoc., v.226, p.393-400, 2005. JACOB F. POLZIN D.J. OSBORNE C.A. Evaluation of the association between initial proteinuria and morbidity rate or death in dogs with naturally occurring chronic renal failure J. Am. Vet. Med. Assoc. 226 393 400 2005 JEPSON, R.E.; BRODBELT, D.; VALLANCE, C. et al. Evaluation of predictors of the development of azotemia in cats. J. Vet. Int. Med., v.23, p.806-813, 2009. JEPSON R.E. BRODBELT D. VALLANCE C. Evaluation of predictors of the development of azotemia in cats J. Vet. Int. Med. 23 806 813 2009 KAWAKAMI, H.; MURAKAMI, T.; KAJIL, T. Normal values for 24-h urinary protein excretion: total and low molecular weigth proteins with a sex-related difference. Clin. Nephrol., v.33, p.232-236, 1990. KAWAKAMI H. MURAKAMI T. KAJIL T Normal values for 24-h urinary protein excretion: total and low molecular weigth proteins with a sex-related difference Clin. Nephrol. 33 232 236 1990 KRIZ, W.; LEHIR, M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int., v.67, p.404-419, 2005. KRIZ W. LEHIR M Pathways to nephron loss starting from glomerular diseases-insights from animal models Kidney Int. 67 404 419 2005 KUWAHARA, Y.; NISHII, N.; TAKASU, M. et al. Use of urine albumin/creatinine ratio for estimation of proteinuria in cat and dogs. J. Vet. Med. Sci., v.70, p.865-867, 2008. KUWAHARA Y. NISHII N. TAKASU M. Use of urine albumin/creatinine ratio for estimation of proteinuria in cat and dogs J. Vet. Med. Sci. 70 865 867 2008 LAEMMLI, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, v.227, p.680-685, 1970. LAEMMLI U.K Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 1970 LAPIN, A.; GABL, F.; KOPSA, H. Diagnostic use of an analysis of urinary proteins by practicable sodium dodecyl sulfate eletrophoresis method and rapid two-dimensional electrophoresis. Electrophoresis, v.10, p.589-595, 1989. LAPIN A. GABL F. KOPSA H Diagnostic use of an analysis of urinary proteins by practicable sodium dodecyl sulfate eletrophoresis method and rapid two-dimensional electrophoresis Electrophoresis 10 589 595 1989 LAU, Y.K.; WOO, K.T. SDS-PAGE is underutilized as a tool for investigating renal patients. Nephron, v.90, p.227-229, 2002. LAU Y.K. WOO K.T SDS-PAGE is underutilized as a tool for investigating renal patients Nephron 90 227 229 2002 LAZARETTI, P.; BAHR, A.; STEINER, J.M. et al. Qualitative changes in proteinuria correlate with changes in kidney structure and functional as X-linked hereditary nephropathy (XLHN) progresses in affected male dogs. J. Vet. Int. Med., v.20, p.737-738, 2006. LAZARETTI P. BAHR A. STEINER J.M. Qualitative changes in proteinuria correlate with changes in kidney structure and functional as X-linked hereditary nephropathy (XLHN) progresses in affected male dogs J. Vet. Int. Med. 20 737 738 2006 LEES, G.E. Early diagnosis of renal disease and renal failure. Vet. Clin. Small Anim. Pract., v.34, p.867-885, 2004. LEES G.E Early diagnosis of renal disease and renal failure Vet. Clin. Small Anim. Pract. 34 867 885 2004 LEES, G.E.; BROWN, S.A.; ELLIOT, J. et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J. Vet. Intern. Med., v.19, p.377-385, 2005. LEES G.E. BROWN S.A. ELLIOT J. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal) J. Vet. Intern. Med. 19 377 385 2005 LITTMAN, M.P. Protein-losing nephropathy in small animals. Vet. Clin. Small Anim. Pract., v.41, p.31-62, 2011. LITTMAN M.P Protein-losing nephropathy in small animals Vet. Clin. Small Anim. Pract. 41 31 62 2011 LULICH, J.P.; OSBORNE, C.A. Interpretation of urine protein-creatinine ratio in dogs with glomerular and nonglomerular disorders. Comp. Cont. Educ. Pract. Vet., v.12, p.59-72, 1990. LULICH J.P. OSBORNE C.A Interpretation of urine protein-creatinine ratio in dogs with glomerular and nonglomerular disorders Comp. Cont. Educ. Pract. Vet. 12 59 72 1990 OSBORNE, C.A.; STEVENS, J.B.; LULICH, J.P. et al. Clinician´s analysis of urinalysis. In: OSBORNE, C.A.; FINCO, D.R. (Eds.). Canine and feline nephrology and urology. Baltimore: Lea and Febiger; 1995. p.136-205. OSBORNE C.A. STEVENS J.B. LULICH J.P. Clinician´s analysis of urinalysis OSBORNE C.A. FINCO D.R Canine and feline nephrology and urology Baltimore Lea and Febiger 1995 136 205 POLZIN, D.J. 11 guidelines for conservatively treating chronic kidney disease. Vet. Med., v.102, p.788-799, 2007. POLZIN D.J 11 guidelines for conservatively treating chronic kidney disease Vet. Med. 102 788 799 2007 POLZIN, D.J. Chronic kidney disease in small animals. Vet. Clin. Small Anim. Pract., v.41, p.15-30, 2011. POLZIN D.J Chronic kidney disease in small animals Vet. Clin. Small Anim. Pract. 41 15 30 2011 RAILA, J.; AUPPERLE, H.; RAILA, G. et al. Renal pathology and urinary protein excretion in a 14-month-old bernese mountain dog with chronic renal failure. J. Vet. Med., v.54, p.131-135, 2007. RAILA J. AUPPERLE H. RAILA G. Renal pathology and urinary protein excretion in a 14-month-old bernese mountain dog with chronic renal failure J. Vet. Med. 54 131 135 2007 REGO, A.B.; KOGIKA, M.M.; SANTORO, M.L. et al. Eletroforese das proteínas urinárias de cães normais e de cães com doença renal em gel de sódio-dodecil-sulfato de poliacrilamida (SDS-PAGE). Vet. Notícias, v.7, p.65-72, 2001. REGO A.B. KOGIKA M.M. SANTORO M.L. Eletroforese das proteínas urinárias de cães normais e de cães com doença renal em gel de sódio-dodecil-sulfato de poliacrilamida (SDS-PAGE) Vet. Notícias 7 65 72 2001 ROUDEBUSH, P.; POLZIN, D.J.; ROSS, S.J. et al. Therapies for feline chronic kidney disease - what is the evidence? J. Feline Med. Surg., v.11, p.195-210, 2009. ROUDEBUSH P. POLZIN D.J. ROSS S.J. Therapies for feline chronic kidney disease - what is the evidence J. Feline Med. Surg. 11 195 210 2009 RUSSO, L.M.; BARKRIS, G.L.; COMPER, W.D. Renal handling of albumin: a critical review of basic concepts and perspective. Am. J. Kidney Dis., v.39, p.899-919, 2002. RUSSO L.M. BARKRIS G.L. COMPER W.D Renal handling of albumin: a critical review of basic concepts and perspective Am. J. Kidney Dis. 39 899 919 2002 SATIRAPOJ, B.; NAST, C.C.; ADLER, S. Novel insights into relationship between glomerular pathology and progressive kidney disease. Adv. Chronic Kidney Dis., v.19, p.93-100, 2012. SATIRAPOJ B. NAST C.C. ADLER S Novel insights into relationship between glomerular pathology and progressive kidney disease Adv. Chronic Kidney Dis. 19 93 100 2012 SCHULTZE, A.E.; JENSEN, R.K. Sodium dodecyl sulfate polyacrilamide gel eletrophoresis of canine urinary proteins for analysis and differentiation of tubular and glomerular diseases. Vet. Clin. Pathol., v.18, p.93-97, 1989. SCHULTZE A.E. JENSEN R.K Sodium dodecyl sulfate polyacrilamide gel eletrophoresis of canine urinary proteins for analysis and differentiation of tubular and glomerular diseases Vet. Clin. Pathol. 18 93 97 1989 SMETS, P.M.Y.; MEYER, E.; MADDENS, B.E.J. et al. Urinary markers in healthy young and ages dogs and dogs with chronic kidney disease. J. Vet. Int. Med., v.24, p.65-72, 2010. SMETS P.M.Y. MEYER E. MADDENS B.E.J. Urinary markers in healthy young and ages dogs and dogs with chronic kidney disease J. Vet. Int. Med. 24 65 72 2010 SYME, H.; ELLIOT, J. Proteinuria and microalbuminuria. In: BARTGES, J.; POLZIN, D.J. Nephrology and urology os small animal. West Sussex: Wilet-Blackwell, 2011.p.410-414. SYME H. ELLIOT J Proteinuria and microalbuminuria BARTGES J. POLZIN D.J Nephrology and urology os small animal West Sussex Wilet-Blackwell 2011 410 414 UECHI, M.; NOGAMI, Y.; TERUI, H. et al. Evaluation of urinary enzymes in dogs with early renal disorder. J. Vet. Med. Sci., v.56, p.555-556, 1994. UECHI M. NOGAMI Y. TERUI H. Evaluation of urinary enzymes in dogs with early renal disorder J. Vet. Med. Sci. 56 555 556 1994 WALLER, K.V.; WARD, K.M.; MAHAN, J.D.; WISMATT, D.K. Current concepts in proteinuria. Clin. Chem., v.35, p.755-765, 1989. WALLER K.V. WARD K.M. MAHAN J.D. WISMATT D.K Current concepts in proteinuria Clin. Chem. 35 755 765 1989 WATANABE, N.; KAMEL, S.; OHKUBO, A. et al. Urinary protein as measured with a pyrogalol red-molybdate complex, manually and in a Hitachi 726 automated analyser. Clin. Chem., v.32, p.1551-1554, 1986. WATANABE N. KAMEL S. OHKUBO A. Urinary protein as measured with a pyrogalol red-molybdate complex, manually and in a Hitachi 726 automated analyser Clin. Chem. 32 1551 1554 1986 WEBER, M.H. Urinary protein analysis. J. Cromathogr., v.429, p.315-344, 1988. WEBER M.H Urinary protein analysis J. Cromathogr. 429 315 344 1988 WHITE, J.V.; OLIVIER, N.B.; REIMANN, K.; JOHNSON, C. Use of protein-creatinine ratio in a single specimen for quantitative estimation of canine proteinuria. J. Am. Vet. Med. Assoc., v.185, p.882-885, 1984. WHITE J.V. OLIVIER N.B. REIMANN K. JOHNSON C Use of protein-creatinine ratio in a single specimen for quantitative estimation of canine proteinuria J. Am. Vet. Med. Assoc. 185 882 885 1984 YABUKI, A.; MITANI, S.; FUJIKI, M. et al. Comparative study of chronic kidney disease in dogs and cats: induction of myofibroblasts. Res. Vet. Sci., v.88, p.294-299, 2010. YABUKI A. MITANI S. FUJIKI M. Comparative study of chronic kidney disease in dogs and cats: induction of myofibroblasts Res. Vet. Sci. 88 294 299 2010 ZARAGOZA, C.; BARRERA, R.; CENTENO, F. et al. Characterization of renal damage in canine leptospirosis by sodium dodecyl suphate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting of the urinary proteins. J. Comp. Pathol., v.129, p.169-178, 2003. ZARAGOZA C. BARRERA R. CENTENO F. Characterization of renal damage in canine leptospirosis by sodium dodecyl suphate-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting of the urinary proteins J. Comp. Pathol. 129 169 178 2003